Citranvi Biosciences

Business Services · North Carolina, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1129 Weaver Dairy Rd Unit 17238, Chapel ...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Citranvi Biosciences

Citranvi Biosciences is a pre-clinical stage company focused on the design and development of innovative vaccine technologies aimed at enhancing immunogenicity for diseases caused by latent viral pathogens, primarily herpesviruses. Their main products include vaccines targeting Human Cytomegalovirus (HCMV) and Epstein-Barr Virus (EBV), which have a significant unmet medical need. The company collaborates with the Henry M. Jackson Foundation for the Advancement of Military Medicine to develop these vaccines, particularly for vulnerable populations such as women of childbearing age and transplant patients. The innovative vaccine platforms are informed by pre-clinical studies and aim to address significant health threats associated with these viral infections.Explore more
Popular SearchesCitranvi Biosciences LLCCitranvi BiosciencesCitranvi LLCSIC Code 87,873NAICS Code 54,541Show more

Citranvi Biosciences Org Chart

PhoneEmail
PF
United States flag for contact location.

Vice President, Immunology

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Citranvi Biosciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Citranvi Biosciences

Compare insights from companies similar to Citranvi Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Citranvi Biosciences

<$5M
1-10
Private
-
-
PF
Phil FernstenVice President, Immunology
<$5M
11-50
Private
-
-
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
1998
<$5M
1-10
Private
<$5M
2005
AR
Armin ReitmairVice President, Translational Research Consulting
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Citranvi Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Citranvi Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Citranvi Biosciences.

Citranvi Biosciences Tech Stack

A closer look at the technologies used by Citranvi Biosciences

Top Business Services Companies

Frequently Asked Questions Regarding Citranvi Biosciences

What is Citranvi Biosciences's official website?
Citranvi Biosciences's official website is www.citranvi.com
What is Citranvi Biosciences's Revenue?
Citranvi Biosciences's revenue is <$5 Million
What is Citranvi Biosciences's SIC code?
Citranvi Biosciences's SIC: 87,873
What is Citranvi Biosciences's NAICS code?
Citranvi Biosciences's NAICS: 54,541
How many employees does Citranvi Biosciences have?
Citranvi Biosciences has 1-10 employees
What industry does Citranvi Biosciences belong to?
Citranvi Biosciences is in the industry of: Business Services, Research & Development
What is Citranvi Biosciences competition?
Citranvi Biosciences top competitors include: Targazyme, Ddnews, GeneCure, Mmmbitesizescience
What technology does Citranvi Biosciences use?
Some of the popular technologies that Citranvi Biosciences uses are: reCAPTCHA, Weebly, Google Workspace, Gmail
What does Citranvi Biosciences do?

Citranvi Biosciences is a pre-clinical stage company focused on the design and development of innovative vaccine technologies aimed at enhancing immunogenicity for diseases caused by latent viral pathogens, primarily herpesviruses. Their main products include vaccines targeting Human Cytomegalovirus (HCMV) and Epstein-Barr Virus (EBV), which have a... significant unmet medical need. The company collaborates with the Henry M. Jackson Foundation for the Advancement of Military Medicine to develop these vaccines, particularly for vulnerable populations such as women of childbearing age and transplant patients. The innovative vaccine platforms are informed by pre-clinical studies and aim to address significant health threats associated with these viral infections.Read More

Is Citranvi Biosciences a public company?
Citranvi Biosciences is private company therefore does not currently have an official ticker symbol
See more information about Citranvi Biosciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.